Thomas S. McHugh, Chief Financial Officer at AVADEL PHARMACEUTICALS PLC (AVDL), bought 2,000 shares at $14.45 ($29K) on 2023-08-14, disclosed to the SEC on 2023-08-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| AVDL | BUY | 2024-01-16 | $29K | — | Filing → |
| AVDL | BUY | 2022-11-30 | $39K | — | Filing → |
| AVDL | BUY | 2022-05-31 | $107K | — | Filing → |